Collegium Pharmaceutical, Inc.

COLLNASDAQHealthcare● Active

$33.27

$-0.11(-0.33%)

Market Cap$1.1B

P/E Ratio—

52W High$50.787

52W Low$29.08

Avg Volume530K

Open$33.43

Beta0.75

Overview

Collegium Pharmaceutical, Inc. (COLL) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

COLL · net income · updated Jun 9, 2026

Core profitability metrics

COLL · net income · margin · TTM · CAGR

Net income was $62.9M for FY2025 (fiscal year ending 2025-12-31), down 9.1% year-over-year. Net profit margin was 8.1%. Based on available data, Collegium Pharmaceutical, Inc. has been profitable since at least 2020.

FY2025 Net Income$62.9M▼ -9.1% YoY

Trailing 12M (TTM)$74.9Mtrailing 4 quarters sum

Net Profit Margin8.1%$62.9M ÷ $780.6M

YoY Change-9.1%—

5-Year CAGR+18.6%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · COLL net income history · COLL profit margin

Annual net income data

COLL · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$62.9M▼ 9.1%8.1%$780.6M

FY2024$69.2M▲ +43.7%11.0%$631.4M

FY2023$48.2M▲ +292.6%8.5%$566.8M

FY2022Loss−$25.0M▼ 135.0%-5.4%$463.9M

FY2021$71.5M▲ +167.3%25.8%$276.9M

Net income vs peers (Healthcare)

COLL vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Collegium Pharmaceutical, Inc.YOU

COLL

$62.9M-9.1%8.1%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Collegium Pharmaceutical, Inc. (COLL) reported net income of $62.9M for FY2025 (fiscal year ending 2025-12-31), down 9.1% year-over-year. The net profit margin was 8.1% — meaning the company kept $0.08 of every dollar of revenue as profit.

Based on available data, Collegium Pharmaceutical, Inc. has been profitable since at least 2020. Net income reached a peak of $71.5M in FY2021. Data available for 13 fiscal years.

Collegium Pharmaceutical, Inc.'s net profit margin was 8.1% for FY2025, based on the latest annual results.

Investors sometimes search for "Collegium Pharmaceutical, Inc. net worth" — the company's market capitalization is a separate figure from COLL net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

COLL net income · 5 questions

Collegium Pharmaceutical, Inc. is profitable. The company reported net income of $62.9M for FY2025, a net profit margin of 8.1%. Net income was down 9.1% year-over-year. Based on available data, Collegium Pharmaceutical, Inc. has been profitable since at least 2020.

is COLL profitabledoes COLL make a profitCOLL profitabilityCOLL profitable company

▸ Source: FMP /income-statement · GAAP · Collegium Pharmaceutical, Inc. · Collegium Pharmaceutical, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026